ArticleAnnals of medicine and surgery (2012)2026
Case report: the unusual association of Kartagener's syndrome and systemic lupus erythematosus.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Kartagener syndrome, or primary ciliary dyskinesia (PCD), is a rare inherited disorder marked by situs inversus, bronchiectasis, and chronic sinusitis due to impaired motile cilia. Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by multisystem inflammation, most commonly affecting skin, joints, kidneys, and other systems. To date, the association between PCD and SLE has not been described. Recognizing this overlap in understanding the interaction between the genetic and autoimmune pathways, ultimately informing tailored diagnostic and therapeutic strategies. Case presentation: A 49-year-old male with a history of Kartagener syndrome, SLE, and visceral inversion presented with multi-system complaints: significant weight loss, fatigue, grade IV dyspnea, diarrhea, vomiting, and fever. Clinical evaluation revealed bilateral pulmonary infiltrates, pleural effusion, and severe renal dysfunction. Laboratory findings showed anemia, electrolyte imbalances, and elevated inflammatory markers. Treatment included IV fluids with electrolyte correction, broad-spectrum antibiotics, and immunosuppressive agents, alongside oral supplements. Clinical discussion: This case spotlights the delicate balance between infection control in PCD and immunosuppression for SLE. Chronic mucociliary clearance defects may perpetuate antigenic stimulation, potentially exacerbating autoimmunity, whereas aggressive immunomodulation can heighten infection risk. No mechanistic link has been established, but our experience underscores the need for integrated multidisciplinary care. Future studies should explore immune profiling in PCD to identify predisposition toward autoimmune disorders. Conclusion: This first-reported concurrence of Kartagener syndrome and SLE emphasizes the importance of holistic evaluation in patients with complex genetic and autoimmune conditions. Awareness of potential cross-talk between ciliary dysfunction and systemic autoimmunity may enhance diagnostic precision and guide individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.